Pathway Medical Partners, LLC
$66.0K 33 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Cambridge Interventional LLC
Cambridge Interventional LLC reported $66,094.25 across General Payments, Research, and Ownership to 36 physicians and teaching hospitals across 36 transactions.
- $66.1K Below-median payer
- All-tracks total
- 36 Below-median volume
- Transactions
- 36 Below-median reach
- Recipients
- −$1.9K
- General Payments vs PY2023
Cambridge Interventional LLC reported $66,094.25 across all CMS Open Payments tracks (General + Research + Ownership) to 36 physicians and teaching hospitals in Program Year 2024 - ranking #1280 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $66,094.25, averaging $1.8K per recipient.
Cambridge Interventional LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
14/100
Total payments
F
11/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer cambridge-interventional-llc Cambridge Interventional LLC
$66.1K · #1280/1,925 · 0.0% industry · PY2024
- TOT $66.1K
- RANK #1280
- SHARE 0.0%
- TXN 36
- RCP 36
- CAT 2
- GEN $66.1K
- ΔGEN −$1.9K
- TOP1 9.6%
- PY 2024
Volume peers
Nearest volume peer: Pathway Medical Partners, LLC ($66.0K)
Cambridge Interventional LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Cambridge Interventional LLC's CMS-reported General Payments decreased by $1.9K (−2.7%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: CAMBRIDGE INTERVENTIONAL LLCPY2023: CAMBRIDGE INTERVENTIONAL LLCPY2024: Cambridge Interventional LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $67,948.68
- PY2024
- $66,094.25
What the Data Shows for Cambridge Interventional LLC
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Cambridge Interventional LLC that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
12 transactions worth $60.0K make "Long-Term Medical Supply or Device Loan" the top general-payment category in the 2-category breakdown below, 90.8% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Cambridge Interventional LLC made 2 types of general payments. "Long-Term Medical Supply or Device Loan" is the largest category at $60.0K, 90.8% of General Payments.
How Cambridge Interventional LLC divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Long-Term Medical Supply or Device Loan | $60.0K | 12 | 90.8% |
| Food and Beverage | $6.1K | 24 | 9.2% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $30,332.23 (45.9%) of $66,094.25 in this company's General Payments records across 33 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Cambridge Interventional LLC
The five named recipients with the highest reported General Payments from this company
- 1
Saka Kazeem
$6,328.63 across 2 reported transactions
- 2
Alireza Falahati-Nini
$6,003.60 across 2 reported transactions
- 3
Sean Nikravan
$6,000.00 across 1 reported transactions
- 4
Brigham And Womens Hospital
$6,000.00 across 1 reported transactions
- 5
Lahey Clinic Hospital Inc.
$6,000.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Cambridge Interventional LLC's spend rank (#1280 of 1,925, bottom 34% by spend) and concentration rank (#1,147 of 1,838, bottom 38% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Fosun Pharma USA Inc. : $42.7K total payments, HHI 763
- LNHC, Inc : $28.7K total payments, HHI 763
- Ipsen Innovation : $349.5K total payments, HHI 763
- Senseonics, Incorporated : $65.4K total payments, HHI 762
- Olympus Corporation of the Americas : $4.7M total payments, HHI 757
- Convergent Dental Inc. : $901.1K total payments, HHI 756
- Cambridge Interventional LLC (this company) : $66.1K total payments, HHI 756
- Exelixis Inc. : $4.0M total payments, HHI 755
- Barco, Inc. : $175.3K total payments, HHI 752
- Urogen Pharma, Inc. : $1.6M total payments, HHI 751
- CapsoVision, Inc. : $966.0K total payments, HHI 748
- Novo Nordisk Health Care AG : $442.0K total payments, HHI 746
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Cambridge Interventional LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Cambridge Interventional LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Cambridge Interventional LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Spinevision SAS
$66.0K 12 recipients
Compare payment profiles
Valinor Pharma, LLC
$65.8K 4,160 recipients
Compare payment profiles
SS White Burs, Inc.
$65.6K 105 recipients
Compare payment profiles
Momentis Surgical Inc.
$66.7K 21 recipients
Compare payment profiles
Swan Valley Medical Incorporated
$65.3K 7 recipients
Compare payment profiles
Put this to use
Cambridge Interventional LLC ranks #1280 of 1,925 by all-tracks total payments, led by "Long-Term Medical Supply or Device Loan".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Long-Term Medical Supply or Device Loan" spend across every manufacturer, not just Cambridge Interventional LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.